Developing antisense oligonucleotide and short‐interfering RNA therapeutics – a few considerations

Publisher: John Wiley & Sons Inc

E-ISSN: 2160-7648|2160-763X|5|323-325

ISSN: 2160-763X

Source: Clinical Pharmacology In Drug Development, Vol.2160-763X, Iss.5, 2015-09, pp. : 323-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract